do glp 1 drugs reduce inflammation GLP-1 calm beyond diabetes and weight loss Weight Reduction with GLP-1 Agonists

These results are similar to those of Azzam et al., 17 who found that GLP-1 RAs contributed to a 72% decrease in blindness or visual abnormalities at 3 months with long-lasting advantages at 24 months

Given all these unknowns, it may be best for Congress to pump the brakes on expanding GLP-1s in Medicare before we have a better understanding of their full value and a way to pay for it.

This is especially important in the context of obesity treatment, where inappropriate prescribing practices have been a concern

Human research remains limited but is expanding

DPP4 plays a major role in glucose metabolism

SGLT2 includes Jardiance, Farxiga, and Invokana Source: IQVIA Market Share Library